Princeton, NJ 08544, U.S.A.
08544
United States of America, New Jersey
Toll free: Carcinomatosis CytoTheray
Phone: 609-452-0927
Fax: Carcinomatosis CytoTheray
Description:
Carcinomatosis – Chinese Cancer Hospital
www.CancerHospital.cn
Empire Medical Criterion
Empire Patient
Carcinomatosis Outflanking Molecular Cytotherapy
1. Derivation
“Carcinomatosis Outflanking Molecular Cytotherapy” is derived from Cancer: A Fact of Life : Cancer is A Systems BioMedicine Disease ( http://CancerHospital.cn/Cancer_SB.pdf ), “Cancer Causes and Risk Factors” ( http://www.cancer.gov/cancertopics/prevention-genetics-causes/causes ) and NCI Think Tanks in Cancer Biology demonstrate cancer is definitely resulting from complex interactions of genetic and environmental influences. ( http://www.cancer.gov/think-tanks-cancer-biology/page9 ). “Cancer arises from one single cell. The transformation from a normal cell into a tumour cell is a multistage process, typically a progression from a pre-cancerous lesion to malignant tumours. The development of cancer may be initiated by external agents and inherited genetic factors.” which is from WHO Fact sheet N°297 for issue of “WHAT CAUSES CANCER ?” and “HOW DOES CANCER DEVELOP ? ( http://www.who.int/mediacentre/factsheets/fs297/en/index.html ) ” Therefore, further unveil why it is that conventional medicine (Surgery, Chemotherapy, Chemical Drugs, Radiotherapy) as allopathic therapy exist in inefficient treatment for cancer.
2. Drive
Cancer: A Fact of Life spontaneously and speedily drive Cancer Treatment into ICBP (Integrative Cancer Biology Program) as A Epochmaking New Oncology for Cancer Innovative Treatment including Nature Medicine , Preventive Medicine and Integrative Medicine which is becoming a major trend for disease solution, not only to cancer patients but also to the current health care systems.
˙Nature Medicine: ( http://www.nature.com/nm/journal/v8/n6/full/nm0602-533.html )
˙Preventive Medicine:
( http://www.elsevier.com/wps/find/journaldescription.cws_home/622934/description?navopenmenu=-2 )
˙Integrative Medicine: ( http://nccam.nih.gov/health/whatiscam/#3 )
˙ICBP (Integrative Cancer Biology Program):
( http://dcb.nci.nih.gov/newsdetail.cfm?ID=11 )
( http://www.nih.gov/news/pr/oct2004/nci-26.htm )
The Integrative Medicine as fulfillment of ICBP, according to OCCAM ( Office of Cancer Complementary and Alternative Medicine) ( http://www.cancer.gov/cam ) and NCI Cancer Proteomics: ( http://www.cancer.gov/cancertopics/factsheet/proteomicsqa ), is emerging to supplement or replace conventional medicine and is becoming a Epochmaking New Oncology in 21st century. Our professional scientist teams have applied ICBP’s Integrative Medicine as Den’quelle Carcinomatosis Outflanking Molecular Cytotherapy which conventional medicine combine Cancer Proteomics and CAM (Complementary and Alternative Medicine) therapies with high-quality evidence of safety and effectiveness to serve cancer patients.
3. Solution
Therefore, Den’quelle Cancer & Carcinomatosis Solution for ICBP (Integrative Cancer Biology Program) as A Epochmaking New Medicine focusing and specializing in cancer prevention and treatment is known as Carcinomatosis Outflanking Molecular Cytotherapy for Integrative Medicine as fulfillment of ICBP ( http://denquelle.com/pdf/Carcinomatosis_CytoTherapy_Abstract.pdf ) derived from our achievements in Nature Medicine, Systems Medicine and Integrative Medicine together with our self developed Den’qulle MediFormula ( http://www.denquelle.com/a.htm?pageName=2_5.htm&Item1=2&Item2=5 ) as In-hospital Preparation, which is what exactly the future trend in cancer prevention and treatment, and this could be well supported by following Initiatives :
◆ Den’quelle Diagnostic Cytopathology Database (DDCD) which is a medicine innovation derived from analogue as ICBP (Integrative Cancer Biology Program) ( http://dcb.nci.nih.gov/newsdetail.cfm?ID=11 ) and caBIG™ (Cancer Biomedical Informatics Grid™) ( https://cabig.nci.nih.gov/ ) to support locale clinic doctors as Den’quelle Biomedical Physician Scientist with interface through Den’quelle Science Services into Den’quelle Systemic Consultation On-Line Synchronism (SCOLS) ( http://www.denquelle.com/a.htm?pageName=3_4.htm&Item1=3&Item2=4 )
◆ Den’quelle BioMedical Products as Den’qulle MediFormula into In-hospital Preparation which is including analogue as CAM (complementary and alternative medicine) from OCCAM (The Office of Cancer Complementary and Alternative Medicine): ( http://www.cancer.gov/cam ) and Cancer Proteomics from NCI (National Cancer Institute) Proteomics and Cancer: ( http://www.cancer.gov/cancertopics/factsheet/proteomicsqa ).
◆ Den’quelle Carcinomatosis Outflanking Molecular Cytotherapy for Integrative Medicine as fulfillment of ICBP with more covering following mechanism:
1. Unraveling the role of DNA repair pathways and DNA repair models.
2. Creating predictive models for cancer defined in terms of cellular modules as pathways.
3. The goal of the Integrative Cancer Biology Program (ICBP) Award entitled “Systems based predictions of responses to cancer therapy” is to develop experimental and computational strategies to predict individual responses to therapies targeted along the Raf-MEK-ERK signaling pathway.
4. Guided by a complex systems approach, the resulting Virtual Tumor will integrate multiple levels of information about cancer, including molecular, cellular, tissue, organ, and patient clinical data.
Comparison in Den’quelle MediFormula vs. Chemical Drug
http://www.denquelle.com/a.htm?pageName=4_4.htm&Item1=4&Item2=4
Drug Side Effects
http://www.denquelle.com/a.htm?pageName=News_1_4.htm&Item1=8
Selected Testimony
http://www.denquelle.com/a.htm?pageName=5_1.htm&Item1=5&Item2=1
Den’quelle Disease Solution ( http://www.denquelle.com/a.htm?pageName=4_2.htm&Item1=4&Item2=2 ) based on our research of Pleiotropic Cytopathic Effect (PCE) corresponding and drawing out Pleiotropic Pharmacodynamics Discovery (PPD), today we have disclosed more than one hundred colonies of cytopathogenetic causes for our PPD on PolyPeptide GlycoProteins, carrier-binding of botanical and herbal glycosides, with which as material ingredient to develop Den’quelle MediFormula targeting on treating colonies of cytopathogenetic causes into Biomedical Products ( http://www.denquelle.com/a.htm?pageName=4_1.htm&Item1=4&Item2=1 ) including Cancer Proteomics which is aimed at clarifying the molecular and cellular mechanisms of cancer promotion and progression.
For discovering targets of Molecular CytoTherapy and Realizing Personalized Medicine, comprehensive protein and gene expression profiling of cancer cell lines, cancer tissues, and sera/plasma of cancer patients has been undertaken.
The ultimate result of One Stop Cancer Systems Package Solution is Group OncoTherapy through Project Practice and Project Management, which we develop personal-tailored total disease solution to each cancer customer as Empire Patient.
Primary Keyword: Cancer Therapy